The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Modelling Myc inhibition as a cancer therapy
Open accessAbstract
Myc is a pleiotropic basic helix–loop–helix leucine zipper transcription factor that coordinates expression of the diverse intracellular and extracellular programs that together are necessary for growth and expansion of somatic cells. In principle, this makes inhibition of Myc an attractive pharmacological approach for treating diverse types of cancer. However, enthusiasm has been muted by lack of direct evidence that Myc inhibition would be therapeutically efficacious, concerns that it would induce serious side effects by inhibiting proliferation of normal tissues, and practical difficulties in designing Myc inhibitory drugs. We have modelled genetically both the therapeutic impact and the side effects of systemic Myc inhibition in a preclinical mouse model of Ras-induced lung adenocarcinoma by reversible, systemic expression of a dominant-interfering Myc mutant. We show that Myc inhibition triggers rapid regression of incipient and established lung tumours, defining an unexpected role for endogenous Myc function in the maintenance of Ras-dependent tumours in vivo. Systemic Myc inhibition also exerts profound effects on normal regenerating tissues. However, these effects are well tolerated over extended periods and rapidly and completely reversible. Our data demonstrate the feasibility of targeting Myc, a common downstream conduit for many oncogenic signals, as an effective, efficient and tumour-specific cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain
Ferré-D'Amaré, A. R., Prendergast, G. C., Ziff, E. B., & Burley, S. K. (1993) · Nature · doi:10.1038/363038a0 · Cited by 724
Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 644
Pelengaris, S., Khan, M., & Evan, G. I. (2002) · Cell · doi:10.1016/s0092-8674(02)00738-9 · Cited by 626
Self-citationOncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
Self-citationThe Differential Effects of Mutant p53 Alleles on Advanced Murine Lung Cancer
Jackson, E. L., Olive, K. P., Tuveson, D. A., Bronson, R., Crowley, D., Brown, M., & Jacks, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2193 · Cited by 553
Reversible Activation of c-Myc in Skin
Pelengaris, S., Littlewood, T., Khan, M., Elia, G., & Evan, G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80350-0 · Cited by 468
Self-citationThe myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Conditional telomerase induction causes proliferation of hair follicle stem cells
Sarin, K. Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., Wang, E., Artandi, M. K., Oro, A. E., & Artandi, S. E. (2005) · Nature · doi:10.1038/nature03836 · Cited by 425
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
Amati, B., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06202.x · Cited by 385
Self-citationDesign and properties of a Myc derivative that efficiently homodimerizes
Soucek, L., Helmer-Citterich, M., Sacco, A., Jucker, R., Cesareni, G., & Nasi, S. (1998) · Oncogene · doi:10.1038/sj.onc.1202199 · Cited by 221
Self-citationWright, D. E., Cheshier, S. H., Wagers, A. J., Randall, T. D., Christensen, J. L., & Weissman, I. L. (2001) · Blood · doi:10.1182/blood.v97.8.2278 · Cited by 208
More than just proliferation: Myc function in stem cells
Murphy, M. J., Wilson, A., & Trumpp, A. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.01.008 · Cited by 187
Baskar, J. F., Smith, P. P., Nilaver, G., Jupp, R. A., Hoffmann, S., Peffer, N. J., Tenney, D. J., Colberg-Poley, A. M., Ghazal, P., & Nelson, J. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3207-3214.1996 · Cited by 166
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek, L., Jucker, R., Panacchia, L., Ricordy, R., Tatò, F., & Nasi, S. (2002) · PubMed · Cited by 160
Self-citationFurth, P. A., Hennighausen, L. G., Baker, C., et al. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.22.6205 · Cited by 135
c-Myc as a therapeutic target in cancer
Prochownik, E. V. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.2.289 · Cited by 112
Chen, J., Willingham, T., Margraf, L. R., Schreiber‐Agus, N., DePinho, R. A., & Nisen, P. D. (1995) · Nature Medicine · doi:10.1038/nm0795-638 · Cited by 105
Omomyc expression in skin prevents Myc-induced papillomatosis
Soucek, L., Nasi, S., & Evan, G. I. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401443 · Cited by 77
Self-citationDefining the temporal requirements for Myc in the progression and maintenance of skin neoplasia
Flores, I., Murphy, D. J., Swigart, L. B., Knies, U. E., & Evan, G. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207796 · Cited by 71
Self-citationStructural Aspects of Interactions Within the Myc/Max/Mad Network
Nair, S. K., & Burley, S. K. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_5 · Cited by 45
Conditionally MYC:insights from novel transgenic models
Arvanitis, C., & Felsher, D. W. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.043 · Cited by 44
Can't kick that oncogene habit
Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.013 · Cited by 21
Self-citationPromoter/Enhancer Cassettes for Keratinocyte Gene Therapy
Sawamura, D., Meng, X., Ina, S., Nakano, H., Tamai, K., Nomura, K., Hanada, K., Hashimoto, I., & Miyazaki, J.-I. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00583.x · Cited by 18
Cited by
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140
“We observed that acute depletion of Myc, in vivo, did not compromise the health of the animals over a period of 1 week, consistent with a recent report (Soucek et al., 2008).”
ResultOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Non-small-cell lung cancers: a heterogeneous set of diseases
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., & Wong, K.-K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3775 · Cited by 1,942
Metadata
- Authors
- Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I.
- Venue
- Nature
- Published
- 2008-08-17
- Volume
- 455
- Issue
- 7213
- Pages
- 679-683
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1990320777
- Cited by
- 817
- References
- 28
- FWCI
- 20.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.